A Social Negotiation of Hope: Male West African Youth, ‘Waithood’ and the Pursuit of Social Becoming Through Football

This work is made available according to the conditions of the Creative Commons Attribution 2.0 Unported (CC BY 3.0) licence. Full details of this licence are available at: http://creativecommons.org/licenses/by/2.0/This paper examines the present-day perception among boys and young men in West Africa that migration through football offers a way to achieve social standing and improve one’s life chances. More specifically, we use the case of aspirant young Ghanaian footballers as a lens to qualify recent conceptualizations of African youth, such as ‘waithood’, which have a tendency to overlook the multifarious attempts and visions of young people on the continent to overcome social immobility. Drawing on various and long-term ethnographic fieldwork among footballers in urban southern Ghana between 2010 and 2016, we argue that young people’s efforts to make it abroad and ‘become a somebody’ through football is not merely an individual fantasy; it is rather a social negotiation of hope. It is this collective practice among a large cohort of young males – realistic or not – which qualifies conceptualizations of youth transitions such as ‘waithood’. By this, we highlight how examining the contemporary fusion of sport with a desire to migrate furthers our understandings of social mobility for West African youth, and extends literature on the strategies used by young people in the region as they try to bypass the structural barriers blocking their path to ‘becoming a somebody’

Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Dimethyl fumarate (DMF) inhibits inflammasome-mediated inflammation and has been proposed as a treatment for patients hospitalised with COVID-19. This randomised, controlled, open-label platform trial (Randomised Evaluation of COVID-19 Therapy [RECOVERY]), is assessing multiple treatments in patients hospitalised for COVID-19 (NCT04381936, ISRCTN50189673). In this assessment of DMF performed at 27 UK hospitals, adults were randomly allocated (1:1) to either usual standard of care alone or usual standard of care plus DMF. The primary outcome was clinical status on day 5 measured on a seven-point ordinal scale. Secondary outcomes were time to sustained improvement in clinical status, time to discharge, day 5 peripheral blood oxygenation, day 5 C-reactive protein, and improvement in day 10 clinical status. Between 2 March 2021 and 18 November 2021, 713 patients were enroled in the DMF evaluation, of whom 356 were randomly allocated to receive usual care plus DMF, and 357 to usual care alone. 95% of patients received corticosteroids as part of routine care. There was no evidence of a beneficial effect of DMF on clinical status at day 5 (common odds ratio of unfavourable outcome 1.12; 95% CI 0.86-1.47; p = 0.40). There was no significant effect of DMF on any secondary outcome

Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Dimethyl fumarate (DMF) inhibits inflammasome-mediated inflammation and has been proposed as a treatment for patients hospitalised with COVID-19. This randomised, controlled, open-label platform trial (Randomised Evaluation of COVID-19 Therapy [RECOVERY]), is assessing multiple treatments in patients hospitalised for COVID-19 (NCT04381936, ISRCTN50189673). In this assessment of DMF performed at 27 UK hospitals, adults were randomly allocated (1:1) to either usual standard of care alone or usual standard of care plus DMF. The primary outcome was clinical status on day 5 measured on a seven-point ordinal scale. Secondary outcomes were time to sustained improvement in clinical status, time to discharge, day 5 peripheral blood oxygenation, day 5 C-reactive protein, and improvement in day 10 clinical status. Between 2 March 2021 and 18 November 2021, 713 patients were enroled in the DMF evaluation, of whom 356 were randomly allocated to receive usual care plus DMF, and 357 to usual care alone. 95% of patients received corticosteroids as part of routine care. There was no evidence of a beneficial effect of DMF on clinical status at day 5 (common odds ratio of unfavourable outcome 1.12; 95% CI 0.86-1.47; p = 0.40). There was no significant effect of DMF on any secondary outcome

The exploitation of Talibé children in Mauritania

Talibés are children, usually boys, who have been sent to Koranic schools, also known as daaras. This is a widespread phenomenon in French-speaking West Africa